TABLE 1.

Comparison of Mean Mid-Regional Pro-Adrenomedullin Values Inpatient Comorbidity Subgroups

Subgroup	No. of Patients	Mean MR-proADM in Subgroup (nmol/L)	Mean MR-proADM in Remaining Population (nmol/L)	Mean Difference (95% CI) (nmol/L)
Cardiac comorbidity	13/792	0.69	0.57	–0.12 (–0.30 to 0.07)
Renal comorbidity	11/792	0.51	0.57	0.06 (–0.14 to 0.26)
Endocrine comorbidity	11/792	0.57	0.57	0.00 (–0.20 to 0.20)
Neonate	13/792	0.78	0.57	–0.22 (–0.40 to –0.04)

MR-proADM = mid-regional pro-adrenomedullin.